Project Grant R41NS076149

This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...

This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $476,993 to Yale University to develop new methods for measuring white matter hyperintensities (WMH) using low-field portable MRI (PMRI) technology. The project aims to create both a qualitative WMH grading scale and a quantitative machine learning-based WMH volume...

This $1,434,445.00 Project Grant award from the National Institutes of Health's Trans-NIH Research Support program (CFDA 93.310) supports the University of Southern California (USC) in developing new deep learning-based architectures, algorithms and training mechanisms to address key challenges in magnetic resonance imaging (MRI) reconstruction. The project aims to create a robust, reliable and trustworthy toolkit for reducing MRI acquisition time, enabling high-quality reconstruction with...

Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Icahn School of Medicine at Mount Sinai a $755,336 Project Grant effective August 1, 2025, through June 30, 2029, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project develops artificial intelligence-powered deep learning models to advance multiple myeloma (MM) patient management and outcomes through automated...

This $276,000 National Science Foundation award through the Technology, Innovation, and Partnerships program will support the development of a cognitive dashboard software platform to aid neurosurgical clinical decision-making. Mindtrace Technologies, Inc. will deliver a turn-key software solution that enables neurosurgical teams to map individual patient brain functions, assess and track measures of mental performance throughout care, and integrate with existing medical imaging and data...

This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the U.S. Department of Health and Human Services, under the Federal Grant Program "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286), aims to develop and assess novel frameworks for accurately predicting functional recovery following moderate-to-severe traumatic brain injury (TBI). The $389,813 award to the University of...

Federal Grant Award Summary Massachusetts General Hospital received a $660,000 Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded on March 15, 2026, with a completion date of February 28, 2029. The award supports development of deep learning-based tools and methodologies to improve the accuracy and accessibility of Alzheimer's disease (AD) diagnosis through structural magnetic resonance imaging (MRI) analysis. Specifically, the project will develop...

Federal Project Grant Award Summary Case Western Reserve University's Office of Research Administration, in affiliation with University Hospitals of Cleveland, received a $109,076 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) on January 10, 2026, with an ultimate completion date of September 9, 2028. The award supports the development and validation of Magnetic Resonance Fingerprinting (MRF) technology for characterizing and...

Federal Grant Award Summary Brigham & Women's Hospital received a $3.16 million Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) awarded on August 14, 2025, with performance through July 31, 2029. The project develops and validates magnetic resonance fingerprinting (MRF) technology to non-invasively image glutamate metabolism in glioblastoma and other brain tumors. The research addresses a critical clinical need by...

Federal Project Grant Award Summary The National Cancer Institute awarded a $382,449 Project Grant to the University of California, Los Angeles under the Cancer Detection and Diagnosis Research program (CFDA 93.394) on July 16, 2025, with completion targeted for June 30, 2027. This research project develops and validates advanced dual-nuclei magnetic resonance imaging (MRI) techniques to non-invasively differentiate between recurrent brain metastases (RBM) and radiation-induced necrosis (RN)...